XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2018
Operating activities:      
Net (loss) income $ (12,717) $ 3,668 $ (1,653)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 13,623 11,801 11,404
Change in fair value of financial instruments 5,974    
Deferred income taxes 3,119 (301) 428
Noncash rental revenue including straight-line rents (2,603) (1,567) (1,669)
Gain on sales of real estate assets (2,329) (7,829) (879)
Impairment loss 2,085 3,100 0
Stock-based compensation expense 510 261 350
Amortization of debt issuance costs 444 313 297
Gain on insurance recovery   (126)  
Other   (182) 172
Changes in assets and liabilities:      
Other assets (997) 499 (123)
Accounts payable and accrued liabilities 1,138 (119) (339)
Deferred revenue 902 1,782 253
Other liabilities (1,001) 135 200
Net cash provided by operating activities 8,148 11,561 8,441
Investing activities:      
Acquisitions of land and buildings (13,670) (10,168)  
Additions to real estate assets (11,326) (29,365) (28,621)
Proceeds from sales of real estate assets, net of expenses 3,086 9,475 998
Proceeds from sales of real estate assets deposited in escrow (1,993)   91
Deferred leasing costs and other (1,793) (959) (802)
Changes in short-term investments, net 1,011 15,989 (17,000)
Net cash used in investing activities (24,685) (15,028) (45,334)
Financing activities:      
Proceeds from sale of common stock 27,281    
Proceeds from mortgage loans 26,600 1,265 31,623
Principal payments on mortgage loans (7,888) (3,953) (15,439)
Net (repayments on) proceeds from revolving lines of credit (5,875) 5,875  
Dividends paid to stockholders (2,538) (2,279) (2,000)
Proceeds from sale of warrants 2,018    
Payment of debt issuance costs (607) (325) (569)
Proceeds from exercise of stock options 212 166 1,802
Net cash provided by financing activities 39,203 749 15,417
Net increase (decrease) in cash and cash equivalents 22,666 (2,718) (21,476)
Cash and cash equivalents at beginning of period 5,874 8,592 30,068
Cash and cash equivalents at end of period $ 28,540 $ 5,874 $ 8,592